Immune checkpoint inhibitors in urothelial carcinoma: Recommendations for practical approaches to pd-l1 and other potential predictive biomarker testing

ANTONIO LOPEZ BELTRAN2026-01-292026-01-29202110.3390/cancers130614242-s2.0-85102700351https://www.scopus.com/inward/record.uri?eid=2-s2.https://ucocris.uco.es/handle/123456789/33106Cancer ResearchOncologyImmune checkpoint inhibitors in urothelial carcinoma: Recommendations for practical approaches to pd-l1 and other potential predictive biomarker testingreview article